The North America Cellulite Treatment Market would witness market growth of 9.5% CAGR during the forecast period (2024-2031).
The US market dominated the North America Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,828.3 Million by 2031. The Canada market is experiencing a CAGR of 10% during (2024 - 2031). Additionally, The Mexico market would experience a CAGR of 10.5% during (2024 - 2031).
Cellulite, often described as the dimpled or lumpy appearance of the skin, affects a large percentage of the population, particularly women, and is commonly found on the thighs, hips, buttocks, and abdomen. Although cellulite does not pose any health risks, it can significantly impair an individual's self-esteem and body image, prompting considerable interest in exploring treatment alternatives.
According to the National Library of Medicine, very little is known about the prevalence and incidence of cellulite and the predisposing factors for cellulite development because of a lack of robust epidemiologic data. Despite this shortcoming, it is widely reported in the literature that an estimated 80% to 90% of postpubertal females are affected by this condition. There is no particular age of onset for cellulite. It can occur at any age postpuberty, although it mostly appears between the ages of 20 and 30. Males are rarely affected by cellulite. In about 2% of males, cellulite may develop due to androgen deficiency secondary to castration, hypogonadism, Klinefelter's syndrome, or estrogen or antiandrogen therapy for prostate cancer.
The increasing demand for cellulite treatment in the US can be linked to the significant growth in the older population. The US Census Bureau estimates that between 1920 and 2020, the population over 65 grew by 50.9 million, or nearly five times the overall population growth rate of approximately 1,000%. Therefore, because of these elements, the regional market will grow rapidly in the coming years.
Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The US market dominated the North America Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,828.3 Million by 2031. The Canada market is experiencing a CAGR of 10% during (2024 - 2031). Additionally, The Mexico market would experience a CAGR of 10.5% during (2024 - 2031).
Cellulite, often described as the dimpled or lumpy appearance of the skin, affects a large percentage of the population, particularly women, and is commonly found on the thighs, hips, buttocks, and abdomen. Although cellulite does not pose any health risks, it can significantly impair an individual's self-esteem and body image, prompting considerable interest in exploring treatment alternatives.
According to the National Library of Medicine, very little is known about the prevalence and incidence of cellulite and the predisposing factors for cellulite development because of a lack of robust epidemiologic data. Despite this shortcoming, it is widely reported in the literature that an estimated 80% to 90% of postpubertal females are affected by this condition. There is no particular age of onset for cellulite. It can occur at any age postpuberty, although it mostly appears between the ages of 20 and 30. Males are rarely affected by cellulite. In about 2% of males, cellulite may develop due to androgen deficiency secondary to castration, hypogonadism, Klinefelter's syndrome, or estrogen or antiandrogen therapy for prostate cancer.
The increasing demand for cellulite treatment in the US can be linked to the significant growth in the older population. The US Census Bureau estimates that between 1920 and 2020, the population over 65 grew by 50.9 million, or nearly five times the overall population growth rate of approximately 1,000%. Therefore, because of these elements, the regional market will grow rapidly in the coming years.
Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Candela Corporation (Syneron Medical)
- Bausch Health Companies, Inc.
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- AbbVie, Inc.
- Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- Hologic, Inc.
- Galderma S.A.
- Zimmer MedizinSysteme GmbH
- Endo International PLC
- Merz Pharma GmbH & Co. KGaA
Market Report Segmentation
By Gender- Female
- Male
- Non-invasive
- Topical
- Minimally Invasive
- Soft Cellulite
- Hard Cellulite
- Edematous
- Clinics & Beauty Centers
- Hospitals
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. North America Cellulite Treatment Market by Gender
Chapter 6. North America Cellulite Treatment Market by Procedure Type
Chapter 7. North America Cellulite Treatment Market by Cellulite Type
Chapter 8. North America Cellulite Treatment Market by End User
Chapter 9. North America Cellulite Treatment Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Candela Corporation (Syneron Medical)
- Bausch Health Companies, Inc.
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- AbbVie, Inc.
- Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- Hologic, Inc.
- Galderma S.A.
- Zimmer MedizinSysteme GmbH
- Endo International PLC
- Merz Pharma GmbH & Co. KGaA
Methodology
LOADING...
